Todd Harris
Patrimonio netto: 43 M $ in data 30/06/2026
Patrimonio netto: 43 M $ in data 30/06/2026
Todd J.
Harris is the founder of Tyra Biosciences, Inc., founded in 2018, holding the titles of President, CEO, Treasurer & Director.
Dr. Harris was the founder of Sienna Biopharmaceuticals, Inc., founded in 2010, holding the titles of Director & Head-Corporate Development from 2016 to 2018.
Dr. Harris currently holds the position of Director at Primmune Therapeutics, Inc. since 2019.
Dr. Harris's education includes a doctorate from Massachusetts Institute of Technology, graduate studies at the University of California San Diego, and an undergraduate degree from Brigham Young University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC 2,28% | 05/05/2026 | 1.358.631 ( 2,28% ) | 43 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Fondatore | 02/08/2018 |
Primmune Therapeutics, Inc.
Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops orally administered toll-like receptor for cancer immunotherapy | Direttore/Membro del Consiglio | 01/10/2019 |
| Società | Posizione | Fine |
|---|---|---|
| SIENNA BIOPHARMACEUTICALS, INC. | Fondatore | 01/07/2018 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Brigham Young University
Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sienna Biopharmaceuticals, Inc.
Sienna Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and manufactures drugs for treating inflammatory skin disorders | Health Technology |
Primmune Therapeutics, Inc.
Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops orally administered toll-like receptor for cancer immunotherapy | Commercial Services |
Tyra Biosciences, Inc.
Tyra Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale